Cathepsin D and carcino-embryonic antigen in serum, urine and tissues of colon adenocarcinoma patients

Hepato-Gastroenterology

Volumn 55, Issue 82-83, 2008, Pages 388-393

  Szajda, Slawomir Dariusz ^a   Snarska, Jadwiga ^a   Jankowska, Anna ^a   Roszkowska Jakimiec, Wieslawa ^a   Puchalski, Zbigniew ^a   Zwierz, Krzysztof ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Colon cancer; Diagnostics; Tumor markers

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CATHEPSIN D; CREATININE; TYROSINE;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER GRADING; CANCER GROWTH; CANCER PATIENT; CELL DIFFERENTIATION; CLINICAL ARTICLE; COLON ADENOCARCINOMA; COLON BIOPSY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE MARKER; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SERUM; TISSUE; TUMOR VOLUME; URINALYSIS; URINE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOEMBRYONIC ANTIGEN; CATHEPSIN D; COLONIC NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 44349083612     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Nagase H, Woessner JF Jr: Matrix metaloproteinases. J Biol Chem 1999; 274:21491-21494.
2. Sylven B, Bois-Svennson I: On the chemical patology of interstitial fluid. Proteolytic activities in transplanted mouse tumors. Cancer Res 1965; 25:458-468.
3. Barrett AJ: Cathepsin D: the lysosomal aspartic proteinase. Ciba Found Symp 1979; 75:37-50.
4. Diment S, Leech MS, Stahl P: Cathepsin D is membrane associated in macrophage endosomes. J Biol Chem 1988; 263:6901-6907.
5. Rochefort H: Biological and clinical significance of cathepsin D in breast cancer. Semin Cancer Biol 1990; 1(2):153-160.
6. Szajda SD, Jankowski M, Zalewska B, Kożuszko B, Gabrylewski W, Skrzydlewski Z: Activity of cancer procoagulant and cathepsin D in breast cancer. Contemp Oncol 2004; 8(3):132-135.
7. Szajda SD, Darewicz B, Kudelski J, Werel T, Zwierz K, Skrzydlewski Z, Gabrylewski W: The cancer procoagulant and cathepsin D activity in blood serum in patients with bladder cancer. Pol Merk Lek 2005; 18(108):651-653.
8. Cavailles V, Augereau P, Rochefort H: Cathepsin D gen of human MCF 7 cells contains estrogen - responsive sequences in its 5 proximal flanking region. Bioch Biophys Res Commun 1991; 174:816-824.
9. Leto G, Tumminello FM, Pizzolanti G, Montalto G, Soresi M, Gebbia N: Lysosomal aspartic and cysteine proteinases serum levels in patients with pancreatic cancer or pancreatitis. Pancreas 1997, 14(1):22-27.
10. Haier J, Nasralla M, Nicolson GL: Cell surface molecules and their prognostic values in assessing colorectal carcinomas. Ann Surg 2000; 321:11-24.
11. Goslin R, Steele G. Jr, Macintyre J, Mayer R, Sugarbaker P, Claghorn K, Wilson R, Zamcheck N: The use of preoperative plasma CEA levels for the stratification of patients after curative resection of colorectal cancer. Ann Surg 1980; 192:747-751.
12. Lucha PA Jr, Rosen L, Olenwine JA, Reed JF, Riether RD, Stasik JJ Jr, Khubchandani IT: Value of carcinoembryonic antigen monitoring in curative surgery for recurrent colorectal carcinoma. Dis Colon Rectum 1997; 40:145-149.
13. Compton C, Fenoglio-Preiser CM, Pettigrew N, Filding LP: American Joint Committee on Cancer Prognostic Factors Consensus Conference: Colorectal Working Group. Cancer 2000; 88:1739-1757.
14. Sansbury LB, Millikan RC, Schroeder JC, Moorman PG, North KE, Sandler RS: Use of nonsteroidal anti-inflammatory drugs and risk of colon cancer in a population-based, case-control study of African Americans and Whites. Am J Epidemiol 2005; 162:548-558.
15. Greczaniuk A, Roszkowska-Jakimiec W, Worowska A, Gacko M: Influence of exogenous chemical compounds on blood plasma cathepsin D activity. Diagn Lab 2001; 37:499-503.
16. Lowry OH, Rosebrought NJ, Farr AL, Frandall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265-275.
17. Scambia G, Benedetti P, Ferrandina G, Battaglia F, Baiocci G, Mancuso S: Cathepsin D assay in ovarian cancer: correlation with pathological features and receptors for oestrogen, progesterone and epidermal growth factor. Br J Cancer 1991; 64(1):182-184.
18. Bessodes M, Antonaskis K, Herscovici J, Garcia M, Rochefort H, Capony F, Lelievre Y, Scherman D: Inhibition of cathepsin D by tripeptides containing statine analogs. Biochem Pharmacol 1999; 58(2):329-333.
19. Szajda SD, Roszkowska-Jakimiec W, Snarska J, Zwierz K: Cathepsin D activity in the blood serum and urine in patients with colonic adenocarcinoma. Contemp Oncol 2006; 10(7):321-323.
20. Kraimps JL, Metaye T, Millet C, Margerit D, Ingrand P, Goujon JM, Levillain P, Babin P, Begon F, Barbier J: Cathepsin D in normal and neoplastic thyroid tissues. Surgery 1995; 118(6):1036-1040.
21. Tumminello FM, Gebbia N, Pizzolanti G, Russo A, Bazan V, Leto G: Cathepsin D content in colorectal cancer. Oncology 1995; 52:237-242.
22. Szajda SD, Kiluk M, Wiśniewski R, Skrzydlweski Z: Diagnostic value of cancer markers CEA, AFP, cathepsin D and cancer procoagulant (CP) in patients with lung and oesophagus cancer. Contemp Oncol 2002; 6(1):9-11.
23. Barnes L, Rao U, Contis L, Schwartz A, Scalamogna P: Salivary duct carcinoma. Part II. Immunohistochemical evaluation of 13 cases for estrogen and progesterone receptors, cathepsin D and c-erbB-2 protein. Oral Sung Oral Med Oral Pathol 1994; 78(1):74-80.
24. Dickinson AJ, Fox SB, Newcomb PV: An immunohistohemical and prognostic evaluation of cathepsin D expression in 105 bladder carcinomas. J Urol 1995; 154(1):237-241.
25. Gion M, Mione R, Diffadi R Romanelli M, Papagnallo L, Capitanio G, Friede U, Barbazza R, Visonà A, Dante S: Relationship between cathepsin D and other pathological and biological parameters in 1752 patients with primary breast cancer. Eur J Cancer 1995; 31:671-677.
26. Matsuo K, Kobayashi I, Takayuki T: Immunohistochemical localization of cathepsin D and E in human gastric cancer. Hum Pathol 1996; 27: 184-196.
27. Gold P, Shuster J, Freedman SO: Carcinoembryonic antigen (CEA) in clinical medicine: historical perspectives, pitfalls and projections. Cancer 1978; 42:1399-1405.